Harvard Bioscience (HBIO)
(Real Time Quote from BATS)
$3.65 USD
+0.09 (2.53%)
Updated Apr 26, 2024 01:20 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
HBIO 3.65 +0.09(2.53%)
Will HBIO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HBIO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HBIO
Watch These 5 Technology Stocks for Q1 Earnings: Beat or Miss?
Harvard Bioscience (HBIO) Q2 Earnings and Revenues Lag Estimates
HBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bruker (BRKR) Surpasses Q2 Earnings and Revenue Estimates
Here's Why Momentum in Harvard Bioscience (HBIO) Should Keep going
3 Instruments Stocks to Watch From a Prospering Industry
Other News for HBIO
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
Harvard Bioscience announces labor force reduction
Harvard Bioscience announces labor force reduction to improve cost structure
Harvard Bioscience Sets Incentive Plan for Top Executives
Sidoti Events, LLC's Virtual March Small-Cap Conference